ESTAZOLAM Side Effects

7002603-7 | Hepatic Function Abnormal
on Sep 10, 2010 Female patient from JAPAN , weighting 118.6 lb, was diagnosed with insomnia, constipation (What is constipation?), hypothyroidism, thrombosis prophylaxis, hyperchlorhydria and was treated with Estazolam (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Estazolam dosage: . During the same period patient was treated with JUNCHO TO (HERBAL PREPARATION) (View Juncho-to (herbal Preparation) Review and Juncho-to (herbal Preparation) Label ), PARAMIDIN (View Paramidin Review and Paramidin Label ), SOLANAX (View Solanax Review and Solanax Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROCYLIN (View Procylin Review and Procylin Label ), ALTAT (View Altat Review and Altat Label ). Patient was hospitalized.

6915551-5 | Gallbladder Polyp, Hepatic Function Abnormal, Hepatic Steatosis
Patient was taking Estazolam (View Usage). Patient had the following side effects: gallbladder polyp, hepatic function abnormal, hepatic steatosis on Jul 30, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, weighting 118.6 lb, was diagnosed with insomnia, constipation (What is constipation?), hypothyroidism, thrombosis prophylaxis, hyperchlorhydria and. Estazolam dosage: . During the same period patient was treated with JUNCHO TO (HERBAL PREPARATION) (View Juncho-to (herbal Preparation) Review and Juncho-to (herbal Preparation) Label ), PARAMIDIN (View Paramidin Review and Paramidin Label ), SOLANAX (View Solanax Review and Solanax Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROCYLIN (View Procylin Review and Procylin Label ), ALTAT (View Altat Review and Altat Label ). Patient was hospitalized.

6872260-9 | Liver Disorder
Adverse event was reported on Jul 14, 2010 by a Female patient taking Estazolam (View Usage) (Dosage: ) was diagnosed with insomnia, constipation (What is constipation?), hypothyroidism, thrombosis prophylaxis, hyperchlorhydria and. Location: JAPAN , 68 years of age, weighting 118.6 lb, After Estazolam was administered, patient had the following side effects: liver disorder. During the same period patient was treated with JUNCHO TO (HERBAL PREPARATION) (View Juncho-to (herbal Preparation) Review and Juncho-to (herbal Preparation) Label ), PARAMIDIN (View Paramidin Review and Paramidin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROCYLIN (View Procylin Review and Procylin Label ), ALTAT (View Altat Review and Altat Label ). Patient was hospitalized.

6871131-1 | Apnoea, Hypotonia, Withdrawal Syndrome
on Jul 13, 2010 Male patient from FRANCE , weighting 5.07 lb, was treated with Estazolam (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, hypotonia, withdrawal syndrome. Estazolam dosage: . During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NOCERTONE (View Nocertone Review and Nocertone Label ), IKARAN (View Ikaran Review and Ikaran Label ), PRAXINOR (View Praxinor Review and Praxinor Label ), ESBERIVEN (View Esberiven Review and Esberiven Label ).


6827310-2 | Hepatic Function Abnormal
on Jul 09, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with insomnia, constipation (What is constipation?), hypothyroidism, thrombosis prophylaxis, hyperchlorhydria and was treated with Estazolam (View Usage). Patient had the following side effects: hepatic function abnormal. Estazolam dosage: . During the same period patient was treated with JUNCHO TO (HERBAL PREPARATION) (View Juncho-to (herbal Preparation) Review and Juncho-to (herbal Preparation) Label ), PARAMIDIN (View Paramidin Review and Paramidin Label ), SOLANAX (View Solanax Review and Solanax Label ), WARFARIN (View Warfarin Review and Warfarin Label ), THYRADIN S (View Thyradin S Review and Thyradin S Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROCYLIN (View Procylin Review and Procylin Label ), ALTAT (View Altat Review and Altat Label ). Patient was hospitalized.

6541944-4 | Agitation, Polydipsia, Water Intoxication
Patient was taking Estazolam (View Usage). After Estazolam was administered, patient had the following side effects: agitation, polydipsia, water intoxication on Jan 13, 2010 from JAPAN Additional patient health information: Male patient , 36 years of age, . Estazolam dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ).

6523289-1 | Agitation, Polydipsia, Water Intoxication
Adverse event was reported on Dec 21, 2009 by a Male patient taking Estazolam (View Usage) (Dosage: ) . Location: JAPAN , 36 years of age, Patient experienced the following unwanted or unexpected effects: agitation, polydipsia, water intoxication. During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ).

6181681-1 | Bradycardia, Electrocardiogram Qt Prolonged
on Apr 24, 2009 Female patient from JAPAN , 33 years of age, was treated with Estazolam (View Usage). Patient had the following side effects: bradycardia, electrocardiogram qt prolonged. Estazolam dosage: Unk. During the same period patient was treated with ROHYPNOL (Unk) (View Rohypnol Review and Rohypnol Label ), MEDETAX (Unk) (View Medetax Review and Medetax Label ), LUVOX (Unk) (View Luvox Review and Luvox Label ), MYSLEE (Unk) (View Myslee Review and Myslee Label ).

6154238-6 | Fall
on Apr 09, 2009 Female patient from JAPAN , 88 years of age, was treated with Estazolam (View Usage). After Estazolam was administered, patient had the following side effects: fall (What is fall?). Estazolam dosage: . During the same period patient was treated with ACETAMINOPHEN W/ PROPOXYPHENE HCL (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ), NOROXIN (View Noroxin Review and Noroxin Label ), TAHOR (View Tahor Review and Tahor Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

4759572-X | Abdominal Pain, Acute Coronary Syndrome, Adenoma Benign, Anaemia, Angina Unstable, Arthralgia, Back Pain, Biliary Dilatation
Patient was taking Estazolam (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), acute coronary syndrome, adenoma benign, anaemia, angina unstable, arthralgia, back pain (What is back pain?), biliary dilatation on Mar 10, 2005 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 149.9 lb, was diagnosed with arthritis (What is arthritis?) and. Estazolam dosage: . During the same period patient was treated with VIOXX (View Vioxx Review and Vioxx Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMBIEN (View Ambien Review and Ambien Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), ANDRODERM (View Androderm Review and Androderm Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), BEXTRA (View Bextra Review and Bextra Label ), CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ). Patient was hospitalized.